Premier League: Manchester United striker Robin van Persie ruled out for a month

Boss David Moyes confirmed Van Persie suffered the injury when he took the corner which led to Phil Jones' goal in the 1-0 Champions League victory over Shakhtar Donetsk on Tuesday. "Robin van Persie is out for a month," said Moyes, who has a number of injury problems going into this weekend's game with Aston Villa. "It is unfortunate because I think if you look at our record with Wayne Rooney and Robin in the team it is actually very good and we have not had them for quite a period recently."Marouane Fellaini has a bit of a back injury. Michael Carrick is missing and Robin is going to miss four weeks with a thigh strain. That is a big blow to us." Goalscoring responsibility will now fall to Rooney who has been in great form this season despite United's problems. Rooney is edging towards Bobby Charlton's club scoring record of 249. Rooney will clock up 500 first-team appearances (including with Everton) on SundayHe's been in the game a long time already but is someone who can go on and play many, many more games." Nemanja Vidic, Patrice Evra and Chris Smalling were also sidelined for the Shakhtar game, while United have suffered back-to-back Premier League defeats against Everton and Newcastle, but Moyes is staying positive about the situation. He said: "I have no doubt it will get better. I am sure we have plenty of players who can cover it and we don't miss them too much." While Moyes does have alternatives to Van Persie, in midfield his squad has been left bereft by the absence of Michael Carrick, who has been sidelined for a month with an Achilles injury. "I do (feel United have felt Carrick's loss)," said Moyes. "We need him for his creativity. We have missed him for lots of other reasons as well. It is important. "We were looking for a couple of midfield players in the summer. We weren't able to get two. We got one. "We needed one who could give us something else if we did get an injury to Michael or one who could have played with him. "We have definitely been a little bit short in that area. Hopefully he is not too far away and he will be back in a couple of weeks and Moyes thinks that, at 28, the England international is getting better. "There are big things ahead for Wayne and some big targets ahead - he can break Sir Bobby's record," Moyes said. "As he gets older, he's adaptable and such a good football player. If he gets older and loses his pace, he can play a bit deeper. There are some fantastic legends around this club and Wayne has got a chance of turning out as one of them."He's been in the game a long time already but is someone who can go on and play many, many more games." Nemanja Vidic, Patrice Evra and Chris Smalling were also sidelined for the Shakhtar game, while United have suffered back-to-back Premier League defeats against Everton and Newcastle, but Moyes is staying positive about the situation. He said: "I have no doubt it will get better. I am sure we have plenty of players who can cover it and we don't miss them too much."While Moyes does have alternatives to Van Persie, in midfield his squad has been left bereft by the absence of Michael Carrick, who has been sidelined for a month with an Achilles injury. "I do (feel United have felt Carrick's loss)," said Moyes. "We need him for his creativity. We have missed him for lots of other reasons as well. It is important. "We were looking for a couple of midfield players in the summer. We weren't able to get two. We got one. "We needed one who could give us something else if we did get an injury to Michael or one who could have played with him. "We have definitely been a little bit short in that area. Hopefully he is not too far away and he will be back in a couple of weeks."

5 Key Principles to Pregnancy Nutrition

If you already eat a healthy diet, there may only be small adjustments you need to make to your diet to ensure you are eating right for the next night months. These five key principles will ensure that you remain fit and healthy, and that baby gets all the nutrients he or she needs to grow to be strong and healthy. #1 Drink Plenty of Water For a healthy pregnancy, it is critical that you drink enough water, as it will help to flush the toxins from your body and fight water retention. Water will also help with constipation and headaches associated with pregnancy. #2 Avoid Processed Foods The best way to begin your pregnancy is with proper nutrition. That includes the elimination of processed foods that are high in fillers, sodium, salt, and preservatives, which could potentially pose a risk to baby. In addition, you are far more likely to gain extra water and suffer with fluid retention when your diet contains processed foods. Instead, opt for healthy, whole food choices that are good for you and baby. #3 Buy Organic Organic foods are becoming more readily available and they are also becoming more affordable. Therefore, your goal should be to buy organic whenever possible. This is especially true when it comes to dairy products, meats, and eggs. Organic foods are higher in amino acids and fatty acids than the non-organic version. When it comes to fruits and vegetables at least make sure that those with the highest pesticide concentrations are organic. These are peaches, celery, apples, strawberries, blueberries, spinach, bell peppers, kale, cherries, grapes, and potatoes. #4 Eat Vegetable With Every Meal As you get further along in your pregnancy it becomes even more important to make sure that you eat vegetables with every meal. They are high in fiber and that will help with constipation associated with pregnancy. You’ll also feel fuller and you’ll obtain tons of nutrients. #5 Every Meal Should Include Healthy Fats Healthy fats include olive oil, organic butter, coconut oil, raw nuts, nut butters, and avocado. These fats will help you to feel full while providing you with nutrients, and they provide the kind of healthy fats that help with your baby’s cognitive development. Include these five key principles in your pregnancy nutrition and you’ll be on your way to well balanced nutrition throughout your pregnancy. Of course, you should always follow your doctor’s orders when it comes to nutrition.

IMAGINE you could disable a car remotely just by pressing a button. It's not a distant dream: devices that use radio waves to disrupt the control computers of modern cars are already in the pipeline. Police will be able to use them to halt suspect vehicles in their tracks. At the request of police in France, Spain and Germany, a European Commission-funded consortium is developing such a device. Meanwhile, electronics firm E2V of Chelmsford, UK, is developing a similar system for both the police and the military, and successfully tested its technology last week. Europe has given €4.3 million to the SAVELEC (Safe Control of Noncooperative Vehicles Through Electromagnetic Means) project. As part of this, engineers at the German Aerospace Center DLR in Stuttgart have pored over automotive Engine Control Units (ECUs) to identify vulnerabilities in microchips that can be exploited using radio signals. The electronics and portable antennas that will transmit those signals are being designed at IMST, a German radio antenna research lab in Kamp-Lintfort. At MBDA, the French missile maker based near Paris, staff are running simulations with large groups of volunteers drivers to gauge how they react when cars cut out at speed. "We want to be able to stop the really powerful cars that we cannot stop with the tools police forces have today," says Cécile Macé, a systems engineer at MBDA. "Really fast cars on the motorway are hard to stop in a safe way," she notes. Police in Dallas, Texas, for instance, last year stopped using stingers –strips of tyre-shredding spikes – after five officers were killed attempting to deploy them. The new devices work not by frying a car's electronics as military electromagnetic pulse weapons do, but by temporarily disabling them. "We want to disturb the car's electronics so we can stop it, but we don't want to break the car and leave it stuck on the motorway. And we don't want to harm the occupants, nearby pedestrians or the police with the beam either," says Macé. Drivers should not feel the beam – but they might hear something. "This is known as the Frey microwave hearing effect and consists of audible clicks... just a pop in the ear," she says. The SAVELEC consortium has yet to test its system, but the aim is to have a prototype ready by 2016. For now, it is releasing few details in order to prevent people from developing countermeasures – or their own version. But the system is likely to be much smaller than the one E2V is working on. Named RF Safe-Stop, E2V's device uses a 350-kilogram transmitter mounted on an SUV and a horn-like metal waveguide to beam microwave pulses at a car or motorbike up to 60 metres away. With the vehicle's wiring acting as an antenna, the pulses disable the ECU temporarily by constantly forcing it to reset itself. That stops the vehicle. E2V gave a proof-of-principle demonstration at Throckmorton airfield in Worcestershire, UK, last week. Both teams need to be wary of unintended consequences, says Jay Abbott of Advanced Security Consulting in Peterborough, UK, warning that the technology might also affect steering and brake systems. "Disrupting all of them at once could potentially leave a car travelling at speed as a dead weight, with limited control over its direction and braking."

IMAGINE you could disable a car remotely just by pressing a button. It's not a distant dream: devices that use radio waves to disrupt the control computers of modern cars are already in the pipeline. Police will be able to use them to halt suspect vehicles in their tracks. At the request of police in France, Spain and Germany, a European Commission-funded consortium is developing such a device. Meanwhile, electronics firm E2V of Chelmsford, UK, is developing a similar system for both the police and the military, and successfully tested its technology last week. Europe has given €4.3 million to the SAVELEC (Safe Control of Noncooperative Vehicles Through Electromagnetic Means) project. As part of this, engineers at the German Aerospace Center DLR in Stuttgart have pored over automotive Engine Control Units (ECUs) to identify vulnerabilities in microchips that can be exploited using radio signals. The electronics and portable antennas that will transmit those signals are being designed at IMST, a German radio antenna research lab in Kamp-Lintfort. At MBDA, the French missile maker based near Paris, staff are running simulations with large groups of volunteers drivers to gauge how they react when cars cut out at speed. "We want to be able to stop the really powerful cars that we cannot stop with the tools police forces have today," says Cécile Macé, a systems engineer at MBDA. "Really fast cars on the motorway are hard to stop in a safe way," she notes. Police in Dallas, Texas, for instance, last year stopped using stingers –strips of tyre-shredding spikes – after five officers were killed attempting to deploy them. The new devices work not by frying a car's electronics as military electromagnetic pulse weapons do, but by temporarily disabling them. "We want to disturb the car's electronics so we can stop it, but we don't want to break the car and leave it stuck on the motorway. And we don't want to harm the occupants, nearby pedestrians or the police with the beam either," says Macé. Drivers should not feel the beam – but they might hear something. "This is known as the Frey microwave hearing effect and consists of audible clicks... just a pop in the ear," she says. The SAVELEC consortium has yet to test its system, but the aim is to have a prototype ready by 2016. For now, it is releasing few details in order to prevent people from developing countermeasures – or their own version. But the system is likely to be much smaller than the one E2V is working on. Named RF Safe-Stop, E2V's device uses a 350-kilogram transmitter mounted on an SUV and a horn-like metal waveguide to beam microwave pulses at a car or motorbike up to 60 metres away. With the vehicle's wiring acting as an antenna, the pulses disable the ECU temporarily by constantly forcing it to reset itself. That stops the vehicle. E2V gave a proof-of-principle demonstration at Throckmorton airfield in Worcestershire, UK, last week. Both teams need to be wary of unintended consequences, says Jay Abbott of Advanced Security Consulting in Peterborough, UK, warning that the technology might also affect steering and brake systems. "Disrupting all of them at once could potentially leave a car travelling at speed as a dead weight, with limited control over its direction and braking."

New Drug Cuts Breast Cancer Risk in Half: Study

The drug Arimidex reduces the risk of developing breast cancer by more than 50 percent among postmenopausal women at high risk for the disease, according to a new study. The finding, scheduled for presentation Thursday at the San Antonio Breast Cancer Symposium in Texas, adds hope that Arimidex (anastrozole) might be a valuable new preventive option for some women. The research will also be published in the journal The Lancet. "Two other antihormone therapies, tamoxifen and raloxifene, are used by some women to prevent breast cancer, but these drugs are not as effective and can have adverse side effects, which limit their use," study lead author Jack Cuzick said in a new release from the American Association for Cancer Research. "Hopefully, our findings will lead to an alternative prevention therapy with fewer side effects for postmenopausal women at high risk for developing breast cancer," said Cuzick, head of the Cancer Research U.K. Centre for Cancer Prevention and director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London. About 80 percent of U.S. breast cancer patients have tumors with high levels of hormone receptors, and these tumors are fueled by the hormone estrogen. Arimidex prevents the body from making estrogen and is therefore used to treat postmenopausal women with hormone receptor-positive breast cancer. The study included more than 3,800 postmenopausal women at increased risk for breast cancer due to having two or more blood relatives with breast cancer, having a mother or sister who developed breast cancer before age 50, or having a mother or sister who had breast cancer in both breasts. About half the women took Arimidex for five years while the others took a placebo, or dummy drug. Those who took the drug were 53 percent less likely to develop breast cancer than those who took the placebo. Side effects among the women taking the drug included hot flashes and small increases in muscle aches and pains. The study received funding from the drug companies AstraZeneca and Sanofi-Aventis, and Cuzick is on the speaker's bureau for AstraZeneca. Two breast cancer experts in the United States expressed optimism about the new findings. "This is very exciting information," said Dr. Amy Tiersten, associate professor of medicine at the Icahn School of Medicine at Mount Sinai, in New York City. She said that although tamoxifen and raloxifene can also cut a woman's odds for breast cancer, "these medications can slightly increase the risk of blood clots and uterine cancer." "It is great to have a less toxic option to offer patients in the preventative arena," she said of Arimidex. Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City, agreed. "It is with open arms that we can add [Arimidex] to the medications that can be offered to postmenopausal women that are at high risk of developing breast cancer," she said. "Because [Arimidex] has less side effects, more women are likely to undergo preventive treatment," Bernik said. "This will eventually help decrease the incidence of breast cancer in women in this category." "We are planning to continue following the study participants for at least 10 years, and hopefully much longer," study author Cuzick said. "We want to determine if [Arimidex] has a continued impact on cancer incidence even after stopping treatment, if it reduces deaths from breast cancer, and to ensure that there are no long-term adverse side effects."

China Rejects More US Corn Amid Rising Trade Conflict

China has blocked the entry of another U.S. corn cargo, and three more may be turned away, after tests found a strain of unapproved genetically-modified corn. But some believe the rejection may have been prompted by other trade disputes between the two countries. The latest cargo of 59,100 tons was denied entry on Tuesday after quarantine officials in the eastern province of Zhejiang detected MIR 162, a GMO strain not yet approved for import by the agriculture ministry, a quarantine official said. Since the middle of November, quarantine authorities in China, the world's second largest corn consumer, have already turned away about 180,000 tons of the grain. "It is really causing big trouble and it seems to be related to bilateral trade conflicts," said a corn trader with a domestic trading house. U.S. government data show that China's appetite for corn remains strong. It was the top destination for U.S. supplies last week, which analysts say outweighs any concerns about the rejections of a few cargoes. The U.S. Agriculture Department said on Monday it inspected 17.6 million bushels of corn earmarked for China last week, which made up 44 percent of the total amount of corn the government inspected. "If they are still importing it, it makes us wonder if this is more of a political game that China is playing," said Terry Reilly, senior commodity analyst at Futures International. "As long as China is taking U.S. corn on a weekly basis ... we are not going to get bearish on this topic." About 2 million tons, or 78.736 million bushels, of U.S. corn is headed for China in ships and China has already committed to buying another 3 million tons of the U.S. grain. China last month fought back against accusations by the United States that it was blocking a World Trade Organization technology deal, with Commerce Minister Gao Hucheng calling the United States "irresponsible." This month, China also launched a trade dispute against the United States to challenge Washington's accusations of having dumped cheap exports on the U.S. market. Traders said another three cargoes had already tested positive for MIR 162, a GMO strain developed for insect resistance, and were expected to be turned away from ports in Guangdong and Fujian. Some are not even being unloaded, making it easier to ship them to other markets, including Japan. "Rejections will be frequent, following large arrivals in coming weeks," said one industry source who asked not to be identified, due to the sensitivity of the issue. "Some cargoes simply berth offshore and buyers are not unloading the cargoes before testing results are complete." The U.S. corn market appeared unaffected by China's rejection. Chicago Board of Trade March corn futures were up 2 cents at $4.29-1/2 a bushel late Wednesday morning. Prices have increased 4.2 percent since China's first rejection in November. Large volumes of the rejected corn have been snapped up by importers in other Asian countries, sometimes with price cuts, European traders said. China expects a record corn harvest this year and faces a massive glut due to weak consumption by the animal feed industry. Its corn output in 2013/14 is likely to rise 5.9 percent on the year to a record 217.7 million tons, surpassing consumption, seen at 197 million. The country's corn consumption fell 1.1 percent from the previous year, partly due to outbreaks of bird flu early in 2013, the China National Grain and Oils Information Center says. Read Latest Breaking News from Newsmax.com http://www.moneynews.com/Markets/GMO-China-corn-reject/2013/12/11/id/541285#ixzz2nJ7lG8XZ Urgent: Should Obamacare Be Repealed? Vote Here Now!

What the Bible Says About Money (Shocking)

Most people know Sean Hyman from his regular appearances on Fox Business, CNBC, and Bloomberg Television, but what they don’t know is that Sean is a former pastor, and that his secret to investing is woven within the Bible. Perhaps that can explain why, despite his uncanny ability to predict precise moves in the stock market, Sean is often laughed at for his unique stance on investing. For example . . . a few months ago Sean appeared on Bloomberg Television. At that time, Best Buy (BBY) was dropping to all-time lows of $16 a share. Sean predicted the stock could go down to $11 a share, and would then quickly rebound to $25 per share, and after that would rally to $40 per share over the next year. Another commentator on the show actually mocked Sean for his stance, saying “$40 on Best Buy? If that’s the case Apple (AAPL) is going to $1,500. That’s the most ridiculous thing I have ever heard!” (Editor’s Note: At the time, Apple was trading at $650 per share). Within a few weeks, Sean would receive the last laugh. Best Buy dropped down to $11.20 a share and has since rebounded up to $42 a share — a 360% gain — exactly as Sean predicted. (Ironically, Apple has dropped down to about $400 per share). During a recent private dinner with Sean, once he’d blessed the food, I wasted no time asking him what his secret is for investing so successfully. I expected Sean to say that it was his years of experience at Charles Schwab or perhaps one of the complicated algorithms he uses for timing the stock market. So when Sean responded that his secret to investing was the Bible, I was thoroughly shocked. Yes, I knew Sean was a Christian (anyone who spends more than 1 minute with him will pick that up!). However, people usually keep their faith separate from things like . . . investing. But not Sean. For Sean, the Bible is his FOUNDATION for investing. He explained to me how there is actually a “Biblical Money Code” woven into Scripture. Sean says it is this Biblical Money Code that took him from making a mere $15,000 a year to now giving away up to $50,000 a year. Sean also credits this code with helping him turn his father’s $40,000 retirement account into $396,000. Certain investment titans, Sean says, such as Warren Buffett and John Templeton, have already used this code to amass billions. What Sean had to say impressed me so much that I asked him to put a presentation together that reveals how anyone could use this “Biblical Money Code.” I’ve personally watched this presentation several times and it is already spreading virally. During the video, Sean uses the teachings of King Solomon, Jesus of Nazareth, and the Apostle Paul to show how anyone can get out of debt . . . make sound investments . . . and morally build substantial wealth. Sean even reveals a “debilitating ‘financial sin’ that blinds many . . . and could be costing you up to 41% of your life savings at this very moment.” What’s so deceiving about this sin is how innocent and safe it appears at first. And at the end, he finishes up with his “12-12-12 plan for investing.” This is a simple step-by-step plan to go from being a saver, to an investor, to a philantropist.

The Tigers have come to terms with free-agent reliever Joba Chamberlain, reports FoxSports.com's Ken Rosenthal. CBSSports.com's Jon Heyman has confirmed the deal. The contract is reported to be for one year at $2.5 million plus incentives. Detroit has already signed Joe Nathan to work as closer, but with Drew Smyly headed to the rotation and Joaquin Benoit unlikely to return, they're in need of bullpen depth. As for the 28-year-old Chamberlain, he's coming off a 2013 in which he logged 4.93 ERA and 1.46 K/BB in 42 relief innings for the Yankees. For his career, he owns a 3.51 ERA out of the bullpen. Chamberlain missed a month last season because of an abdominal strain, underwent Tommy John surgery in June 2011 and then suffered a serious ankle dislocation in March of 2012. As a rookie in 2007, Chamberlain was dominant in limited action. After the Yankees attempted to make him into a starter, however, his performance suffered, even after being returned to a relief role. A change of scenery and coaching might do Chamberlain well.

The Tigers have come to terms with free-agent reliever Joba Chamberlain, reports FoxSports.com's Ken Rosenthal. CBSSports.com's Jon Heyman has confirmed the deal. The contract is reported to be for one year at $2.5 million plus incentives. Detroit has already signed Joe Nathan to work as closer, but with Drew Smyly headed to the rotation and Joaquin Benoit unlikely to return, they're in need of bullpen depth. As for the 28-year-old Chamberlain, he's coming off a 2013 in which he logged 4.93 ERA and 1.46 K/BB in 42 relief innings for the Yankees. For his career, he owns a 3.51 ERA out of the bullpen. Chamberlain missed a month last season because of an abdominal strain, underwent Tommy John surgery in June 2011 and then suffered a serious ankle dislocation in March of 2012. As a rookie in 2007, Chamberlain was dominant in limited action. After the Yankees attempted to make him into a starter, however, his performance suffered, even after being returned to a relief role. A change of scenery and coaching might do Chamberlain well.